Visiomed Group SA (ALVMG) | Stock Overview & Key Data
Visiomed Group SA Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €173.86 on December 15, 2014
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2023
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Visiomed Group SA
ALVMG
|
52.83M Small-cap | 5.56% | -5.00% | 5.56% | 5.56% | 5.56% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 88.12B Large-cap | 6.30% | 6.23% | -6.90% | -6.90% | -6.90% | -6.21% | -6.21% | -6.21% | -6.21% | -6.21% | -6.21% | |
|
Sartorius Stedim
DIM
|
15.79B Large-cap | -2.23% | 12.51% | 3.06% | 3.06% | 3.06% | 6.42% | 6.42% | 6.42% | 6.42% | 6.42% | 6.42% |
|
Crossject S.A
ALCJ
|
105.59M Small-cap | 1.05% | 1.05% | -3.98% | -7.21% | -9.81% | 6.04% | -50.89% | -39.31% | -72.74% | -83.28% | -83.28% |
|
Spineway S.A
ALSPW
|
5.76M Small-cap | -7.69% | -14.29% | -25.00% | -25.00% | -25.00% | -25.00% | -25.00% | -25.00% | -25.00% | -25.00% | -25.00% |
|
Bonyf N.V
MLBON
|
2.48M Small-cap | 0.00% | -0.47% | -6.25% | -67.44% | -14.29% | -69.78% | -65.00% | -66.40% | -66.40% | -66.40% | -66.40% |
Ownership & Short Interest
Calculate Your Visiomed Group SA Investment Returns
Long-Term Investment Performance Analysis
Visiomed Group SA stock price in Mar 2026 was €0.18, A €1,000.00 lump sum investment in Visiomed Group SA made 0 years ago would be worth approximately €1,055.56 today, representing a positive return of 5.56%.
2 Months Investment Scenario (Mar 2026 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ALVMG's 52-week high and low?
- In the last 52 weeks, Visiomed Group SA reached a high of €0.31 (on September 26, 2025) and a low of €0.15 (on March 20, 2026).
- What is the market cap and P/E ratio for ALVMG?
- Curious about Visiomed Group SA's size and valuation? Its market capitalization stands at 52.83M. When it comes to valuation, the P/E ratio (trailing twelve months) is 59.67, and the forward P/E (looking ahead) is 5.75.
- Does ALVMG pay dividends? If so, what's the yield?
- As for dividends, Visiomed Group SA isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Visiomed Group SA's main competitors or similar companies to consider before investing?
When looking at Visiomed Group SA, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return EssilorLuxottica
EL88.12B Healthcare Medical Instruments & Supplies -6.21% -6.21% Sartorius Stedim
DIM15.79B Healthcare Medical Instruments & Supplies 6.42% 6.42% Crossject S.A
ALCJ105.59M Healthcare Medical Instruments & Supplies 6.04% -50.89% Spineway S.A
ALSPW5.76M Healthcare Medical Instruments & Supplies -25.00% -25.00% Bonyf N.V
MLBON2.48M Healthcare Medical Instruments & Supplies -69.78% -65.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Visiomed Group SA? (e.g., ROE, Debt/Equity)
- To get a sense of Visiomed Group SA's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 3.64%, the Debt to Equity ratio from the most recent quarter is 0.32, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALVMG?
- Looking at Visiomed Group SA's growth, its revenue over the trailing twelve months (TTM) was €14M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of ALVMG stock is held by insiders and institutions?
- Wondering who owns Visiomed Group SA stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.